Path: number1.nntp.ams.giganews.com!number1.nntp.dca.giganews.com!border1.nntp.dca.giganews.com!nntp.giganews.com!pd7cy2so!shaw.ca!pd7tw2no.POSTED!53ab2750!not-for-mail
From: "kr0" 
Newsgroups: fidonet.stock_market
Subject: Inspire Pharmaceuticals Securities Fraud
Lines: 11
Message-ID: 
Date: Fri, 18 Feb 2005 15:25:53 GMT
NNTP-Posting-Host: 24.64.223.206
NNTP-Posting-Date: Fri, 18 Feb 2005 08:25:53 MST
Organization: Shaw Residential Internet
Xref: number1.nntp.dca.giganews.com fidonet.stock_market:181

There appears to be a securities fraud violation regarding Inspire
Pharmaceuticals stock. Apparently, as a result of Inspire Pharma's failure
to inform the market of a primary endpoint to a clinical trial they may have
devalued the stock.  If you go to
http://www.lawyersandsettlements.com/case/inspire there is more information
on this and what you can do about it. There is also a free case evaluation
that may be of help to some.

kr0